WORKING EXPERIENCES
• August 2005 –September 2007
Research Associate  at the Dept. of Pathology of Peking University
• September 2007 –present
Instructor at the Dept. of Pathology of Peking University

EDUCATION 
• 2008 - 2010 University Medical Center Groningen, The Netherlands   
PhD in Pathology
Subject: HLA-linked Genetic Susceptibility to classical Hodgkin Lymphoma
•2005 - 2002 Peking University                                                                         
Medical Master in Pathology   
•1996 - 2001 Wuhan University                                                                          
Bachelor in Medicine

PUBLICATIONS
1) Huang X, Kushekhar K, Nolte I, Kooistra W, Visser L, et al. (2012) HLA Associations in Classical Hodgkin Lymphoma: EBV Status Matters. PLoS ONE 7(7): e39986. doi:10.1371/journal.pone.0039986
2) Huang X, Hepkema B, Nolte I, Kushekhar K, Jongsma T, et al. (2012) HLA-A*02:07 Is a Protective Allele for EBV Negative and a Susceptibility Allele for EBV Positive Classical Hodgkin Lymphoma in China. PLoS ONE 7(2): e31865. doi:10.1371/journal.pone.0031865
3) Xu C, Plattel W, Berg A, Rüther N, Huang X, et al. (2011) Expression of the c-Met oncogene by tumor cells predicts favorable outcome in classical Hodgkin lymphoma. Haematologica. 2011; 96: Epub ahead of print doi:10.3324/haematol.2011.056101
4) Huang X, Nolte I, Gao Z, Vos H, Hepkema B, et al.(2011) Epidemiology of Classical Hodgkin Lymphoma and Its Association with Epstein Barr Virus in Northern China. PLoS ONE 6(6): e21152. doi:10.1371/journal.pone.0021152
5) Huang X, van den Berg A, Gao Z, Visser L, Nolte I, et al. (2010) Expression of HLA Class I and HLA Class II by Tumor Cells in Chinese Classical Hodgkin Lymphoma Patients. PLoS ONE 5(5): e10865. doi:10.1371/journal.pone.0010865

GRANTS
Research Program of National Natural Science Foundation of China (Grant No. 81201859): Prognostic and predictive impact of intra-tumoral immune infiltrates in relation to EBV status in classical Hodgkin Lymphoma